ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The Leadership Development Group Welcomes Rosemary Bloser As Vice President, Client Solutions

NEW YORK, NY / ACCESSWIRE / April 15, 2021 / The Leadership Development Group, Inc (TLD Group), a global leadership and team development firm, is delighted to welcome Rosemary Mesisca Bloser, MBA as Vice President, Client Solutions. Rosemary, who was previously Managing Partner at Enterprise Learning Solutions (ELS), and Practice Leader, Healthcare and Life Sciences, at the Aresty Institute of Executive Education, the Wharton School, University of Pennsylvania, is a strategic learning and development professional with deep experience in complex problem solving, building relationships, and designing and delivering learning solutions.

"As we expand our reach across the various sectors of the health ecosystem, we are excited to welcome Rosemary to the team. We will draw from Rosemary's experience and healthcare background in new business development, client relationship management, and clinical and research administration to enable TLD Group to continue to provide an unparalleled customer experience for our clients," said Tracy Duberman, PhD, President and CEO of TLD Group.

At ELS, Rosemary assessed industry trends and linked cutting edge research and faculty thought leadership to help develop new, practical content. Prior to ELS, she was responsible for client relationships, team leadership, and design of custom executive development programs at the Wharton School. Formerly, Rosemary was Managing Director for Health Care Management Executive Education at Penn's Leonard Davis Institute of Health Economics (LDI), spent a decade in clinical and research administration with the University of Pennsylvania Health System as the Clinical Department Administrator for General Internal Medicine and Sidney Kimmel Medical College at Thomas Jefferson University as the Director of Financial Operations for the Department of Medicine.

Rosemary's client list includes Association of American Medical Colleges, Children's Hospital of Philadelphia, GlaxoSmithKline, Novartis, Temple University Health System, Trinity Health, and the University of Pennsylvania Health System (Penn Medicine). Rosemary earned her MBA (concentration Information Systems) from Rutgers University and holds a BS in Business Administration from the University of Delaware. She lives in Wilmington, Delaware with her husband and three children.

"My global health care and academic experience coupled with my leadership development experience makes TLD Group a terrific home for me," said Rosemary Bloser. "I look forward to working with TLD Group's world-class faculty and contributing to TLD Group's thought leadership."

The Leadership Development Group (TLD Group) is a full service health ecosystem talent development firm offering customized solutions to help leaders and teams execute strategy through a combination of innovative solutions including Executive Coaching, Team Development Consulting, Leadership Academies and Physician Leadership Training. TLD Group also offers several featured offerings including Virtual Leadership Development, COVID-19 Leadership Support, and Equity, Diversity & Inclusion Programs. For more information on developing customized leadership programs, visit https://www.tldgroupinc.com/.

For further information, contact:

Amy Riemer, Media Relations
978-475-4441 (office) or 978-502-4895 (cell)
amy@riemercommunications.com

SOURCE: The Leadership Development Group



View source version on accesswire.com:
https://www.accesswire.com/640393/The-Leadership-Development-Group-Welcomes-Rosemary-Bloser-As-Vice-President-Client-Solutions

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.